Cargando…

Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex

Cancer stem cells (CSCs) are linked to tumour relapse and metastasis, the main reason for cancer-related deaths. The application of polymeric nanoparticles as drug delivery systems to target CSCs is relatively unexplored. Here, we report the encapsulation of a CSC-potent copper(II) complex 1 by two...

Descripción completa

Detalles Bibliográficos
Autores principales: Passeri, Ginevra, Northcote-Smith, Joshua, Suntharalingam, Kogularamanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051418/
https://www.ncbi.nlm.nih.gov/pubmed/36985478
http://dx.doi.org/10.3390/molecules28062506
_version_ 1785014881360019456
author Passeri, Ginevra
Northcote-Smith, Joshua
Suntharalingam, Kogularamanan
author_facet Passeri, Ginevra
Northcote-Smith, Joshua
Suntharalingam, Kogularamanan
author_sort Passeri, Ginevra
collection PubMed
description Cancer stem cells (CSCs) are linked to tumour relapse and metastasis, the main reason for cancer-related deaths. The application of polymeric nanoparticles as drug delivery systems to target CSCs is relatively unexplored. Here, we report the encapsulation of a CSC-potent copper(II) complex 1 by two compositionally different methoxy poly(ethylene glycol)-b-poly(D,L-lactic-co-glycolic) acid (PEG–PLGA) copolymers. Specifically, we used PEG–PLGA (5000:10,000 Da, 1:1 LA:GA) and PEG–PLGA (5000:10,000 Da, 4:1 LA:GA) polymers to prepare spherical nanoparticle formulations 1:1 NP(15) and 4:1 NP(15), respectively, both with a 15% feed of 1. The two formulations show distinct biophysical and in vitro properties. For example, (i) 4:1 NP(15) displays a slower payload release profile than 1:1 NP(15) in physiologically relevant solutions, (ii) 4:1 NP(15) exhibits statistically greater potency towards breast CSCs than bulk breast cancer cells grown in monolayers, whereas 1:1 NP(15) is equally potent towards breast CSCs and bulk breast cancer cells, and (iii) 4:1 NP(15) shows significantly greater potency towards three-dimensionally cultured mammospheres than 1:1 NP(15). This study shows that the release profile and anti-breast CSC properties of PEG–PLGA nanoparticle formulations (containing 1) can be perturbed (and possibly controlled) by modifying the proportion of glycolic acid within the PLGA component.
format Online
Article
Text
id pubmed-10051418
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100514182023-03-30 Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex Passeri, Ginevra Northcote-Smith, Joshua Suntharalingam, Kogularamanan Molecules Article Cancer stem cells (CSCs) are linked to tumour relapse and metastasis, the main reason for cancer-related deaths. The application of polymeric nanoparticles as drug delivery systems to target CSCs is relatively unexplored. Here, we report the encapsulation of a CSC-potent copper(II) complex 1 by two compositionally different methoxy poly(ethylene glycol)-b-poly(D,L-lactic-co-glycolic) acid (PEG–PLGA) copolymers. Specifically, we used PEG–PLGA (5000:10,000 Da, 1:1 LA:GA) and PEG–PLGA (5000:10,000 Da, 4:1 LA:GA) polymers to prepare spherical nanoparticle formulations 1:1 NP(15) and 4:1 NP(15), respectively, both with a 15% feed of 1. The two formulations show distinct biophysical and in vitro properties. For example, (i) 4:1 NP(15) displays a slower payload release profile than 1:1 NP(15) in physiologically relevant solutions, (ii) 4:1 NP(15) exhibits statistically greater potency towards breast CSCs than bulk breast cancer cells grown in monolayers, whereas 1:1 NP(15) is equally potent towards breast CSCs and bulk breast cancer cells, and (iii) 4:1 NP(15) shows significantly greater potency towards three-dimensionally cultured mammospheres than 1:1 NP(15). This study shows that the release profile and anti-breast CSC properties of PEG–PLGA nanoparticle formulations (containing 1) can be perturbed (and possibly controlled) by modifying the proportion of glycolic acid within the PLGA component. MDPI 2023-03-09 /pmc/articles/PMC10051418/ /pubmed/36985478 http://dx.doi.org/10.3390/molecules28062506 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Passeri, Ginevra
Northcote-Smith, Joshua
Suntharalingam, Kogularamanan
Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex
title Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex
title_full Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex
title_fullStr Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex
title_full_unstemmed Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex
title_short Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex
title_sort payload release profile and anti-cancer stem cell properties of compositionally different polymeric nanoparticles containing a copper(ii) complex
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051418/
https://www.ncbi.nlm.nih.gov/pubmed/36985478
http://dx.doi.org/10.3390/molecules28062506
work_keys_str_mv AT passeriginevra payloadreleaseprofileandanticancerstemcellpropertiesofcompositionallydifferentpolymericnanoparticlescontainingacopperiicomplex
AT northcotesmithjoshua payloadreleaseprofileandanticancerstemcellpropertiesofcompositionallydifferentpolymericnanoparticlescontainingacopperiicomplex
AT suntharalingamkogularamanan payloadreleaseprofileandanticancerstemcellpropertiesofcompositionallydifferentpolymericnanoparticlescontainingacopperiicomplex